(d(CH2)51,Tyr(Me)2,Thr4,Orn8,Tyr-NH29)-Vasotocin

(d(CH2)51,Tyr(Me)2,Thr4,Orn8,Tyr-NH29)-Vasotocin is a modified vasotocin analog with a cyclized backbone, methylated tyrosine, and substituted threonine and ornithine residues, increasing receptor affinity and stability. The peptide is employed to study vasotocin's role in regulating smooth muscle contraction and fluid balance. Researchers use it in cardiovascular and neuropeptide signaling studies.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.

CAT No: O06013

CAS No:114056-26-7

Synonyms/Alias:OVTA

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Peptide Analysis ServicesPeptide Synthesis ServicescGMP Peptide ServicePeptide Nucleic Acids SynthesisEpitope Mapping ServicesPeptide CDMOCustom Conjugation ServicePeptide Modification Services
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers